BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23458702)

  • 1. Potential of an age-stratified CA125 cut-off value to improve the prognostic classification of patients with endometrial cancer.
    Chao A; Tang YH; Lai CH; Chang CJ; Chang SC; Wu TI; Hsueh S; Wang CJ; Chou HH; Chang TC
    Gynecol Oncol; 2013 Jun; 129(3):500-4. PubMed ID: 23458702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of pre-operative serum CA125 level for prediction of prognosis in patients with endometrial cancer.
    Chen YL; Huang CY; Chien TY; Huang SH; Wu CJ; Ho CM
    Aust N Z J Obstet Gynaecol; 2011 Oct; 51(5):397-402. PubMed ID: 21806586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic role of preoperative serum CA125 levels in patients with advanced endometrial carcinoma.
    Modarres-Gilani M; Vaezi M; Shariat M; Zamani N; Nourizadeh R
    Cancer Biomark; 2017 Aug; 20(2):135-141. PubMed ID: 28800309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of the minimum apparent diffusion coefficient (ADCmin) of the primary tumor and CA125 are predictive of disease recurrence for patients with endometrial cancer.
    Nakamura K; Imafuku N; Nishida T; Niwa I; Joja I; Hongo A; Kodama J; Hiramatsu Y
    Gynecol Oncol; 2012 Feb; 124(2):335-9. PubMed ID: 22008707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum tetranectin and CA125 in endometrial adenocarcinoma.
    Lundstrøm MS; Høgdall CK; Nielsen AL; Nyholm HC
    Anticancer Res; 2000; 20(5C):3903-6. PubMed ID: 11268474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative serum CA125: a useful marker for surgical management of endometrial cancer.
    Jiang T; Huang L; Zhang S
    BMC Cancer; 2015 May; 15():396. PubMed ID: 25964114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer.
    Chung HH; Kim JW; Park NH; Song YS; Kang SB; Lee HP
    Acta Obstet Gynecol Scand; 2006; 85(12):1501-5. PubMed ID: 17260229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET).
    Antonsen SL; Høgdall E; Christensen IJ; Lydolph M; Tabor A; Loft Jakobsen A; Fagö-Olsen CL; Andersen ES; Jochumsen K; Høgdall C
    Acta Obstet Gynecol Scand; 2013 Nov; 92(11):1313-22. PubMed ID: 24032654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HE4 is an independent prognostic marker in endometrial cancer patients.
    Mutz-Dehbalaie I; Egle D; Fessler S; Hubalek M; Fiegl H; Marth C; Widschwendter A
    Gynecol Oncol; 2012 Aug; 126(2):186-91. PubMed ID: 22525819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum HE4 as a prognostic marker in endometrial cancer--a population based study.
    Brennan DJ; Hackethal A; Metcalf AM; Coward J; Ferguson K; Oehler MK; Quinn MA; Janda M; Leung Y; Freemantle M; ; Webb PM; Spurdle AB; Obermair A
    Gynecol Oncol; 2014 Jan; 132(1):159-65. PubMed ID: 24211402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-stratification of endometrial carcinomas revisited: a combined preoperative and intraoperative scoring system for a reliable prediction of an advanced disease.
    Tuomi T; Pasanen A; Luomaranta A; Leminen A; Bützow R; Loukovaara M
    Gynecol Oncol; 2015 Apr; 137(1):23-7. PubMed ID: 25643690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy.
    Juretzka MM; Barakat RR; Chi DS; Iasonos A; Dupont J; Abu-Rustum NR; Poynor EA; Aghajanian C; Spriggs D; Hensley ML; Sabbatini P
    Gynecol Oncol; 2007 Jan; 104(1):176-80. PubMed ID: 16996584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preoperative serum CA125 can predict the lymph node metastasis in endometrioid-type endometrial cancer.
    Ünsal M; Kimyon Comert G; Karalok A; Basaran D; Turkmen O; Boyraz G; Tasci T; Koc S; Boran N; Tulunay G; Turan T
    Ginekol Pol; 2018; 89(11):599-606. PubMed ID: 30508211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between serum CA125 level and prognosis in the patients with uterine endometrial carcinoma].
    Xie Z; Zhang J; Tan A
    Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(23):1456-7. PubMed ID: 11930622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of pre-operative serum tetranectin, CA-125 and a combined index in women with primary ovarian cancer.
    Høgdall CK; Nørgaard-Pedersen B; Mogensen O
    Anticancer Res; 2002; 22(3):1765-8. PubMed ID: 12168866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of serum CA125 levels in patients with high-risk, early stage epithelial ovarian cancer.
    Kang WD; Choi HS; Kim SM
    Gynecol Oncol; 2010 Jan; 116(1):57-60. PubMed ID: 19818996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of serum human epididymis protein 4 and cancer antigen 125 concentrations in endometrial carcinoma.
    Saarelainen SK; Peltonen N; Lehtimäki T; Perheentupa A; Vuento MH; Mäenpää JU
    Am J Obstet Gynecol; 2013 Aug; 209(2):142.e1-6. PubMed ID: 23583212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of elevated preoperative serum CA125 in ovarian tumors of low malignant potential: a multinational collaborative study (ANZGOG0801).
    Tang A; Kondalsamy-Chennakesavan S; Ngan H; Zusterzeel P; Quinn M; Carter J; Leung Y; Obermair A
    Gynecol Oncol; 2012 Jul; 126(1):36-40. PubMed ID: 22370601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of serum CA125 level in patients with advanced non-small cell lung cancer].
    Hu Y; Zhong A; Yang X
    Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):30-1. PubMed ID: 11776591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of serum CA-125 levels for preoperative counseling in endometrioid endometrial cancer: a multi-center study.
    Kim HS; Park CY; Lee JM; Lee JK; Cho CH; Kim SM; Kim JW
    Gynecol Oncol; 2010 Sep; 118(3):283-8. PubMed ID: 20541245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.